Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now notes that items are auto-filled from PubMed and may not pertain to the study, and the revision label in the page footer changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check27 days agoChange DetectedThe government funding/operating-status notice was removed. The study details, eligibility criteria, and enrollment information remain unchanged.SummaryDifference0.4%

- Check49 days agoChange DetectedNo additions or deletions were detected; the page's core content and study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- Updated version from v3.1.0 to v3.2.0. - Added a government-operating-status notice about funding lapse and the NIH Clinical Center openness, directing users to cc.nih.gov and opm.gov for status updates.SummaryDifference3%

- Check78 days agoChange DetectedUpdate the page's version identifier from v3.0.2 to v3.1.0.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; 'Back to Top' was removed.SummaryDifference0.2%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.